scholarly journals Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months

2013 ◽  
Vol 14 (1) ◽  
Author(s):  
Wendy L St Peter ◽  
◽  
Stephen M Sozio ◽  
Tariq Shafi ◽  
Patti L Ephraim ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Medication Use ◽  
Blood Pressure Medication ◽  
Dialysis Patients

Association Between Cardiometabolic Factors and Dizziness in African Americans: The Jackson Heart Study

2021 ◽  
Author(s):  
Amrita Ray ◽  
Christopher Spankovich ◽  
Charles E. Bishop ◽  
Dan Su ◽  
Yuan-I Min ◽  
...  
Keyword(s):  
Blood Pressure ◽  
African American ◽  
African Americans ◽  
Noise Exposure ◽  
Medication Use ◽  
Blood Pressure Medication ◽  
Jackson Heart Study ◽  
Screening Questionnaire ◽  
Heart Study ◽  
Cardiometabolic Factors

Abstract Background Balance dysfunction is a complex, disabling health condition that can present with multiple phenotypes and etiologies. Data regarding prevalence, characterization of dizziness, or associated factors is limited, especially in an African American population. Purpose The aim of the study is to characterize balance dysfunction presentation and prevalence in an African American cohort, and balance dysfunction relationship to cardiometabolic factors. Research Design The study design is descriptive, cross sectional analysis. Study Sample The study sample consist of N = 1,314, participants in the Jackson Heart Study (JHS). Data Collection and Analysis JHS participants were presented an initial Hearing health screening questionnaire (N = 1,314). Of these, 317 participants reported dizziness and completed a follow-up Dizziness History Questionnaire. Descriptive analysis was used to compare differences in the cohorts' social-demographic characteristics and cardiometabolic variables to the 997 participants who did not report dizziness on the initial screening questionnaire. Based on questionnaire responses, participants were grouped into dizziness profiles (orthostatic, migraine, and vestibular) to further examine differences in cardiometabolic markers as related to different profiles of dizziness. Logistical regression models were adjusted for age, sex, education, reported noise exposure, and hearing sensitivity. Results Participants that reported any dizziness were slightly older and predominantly women. Other significant complaints in the dizzy versus nondizzy cohort included hearing loss, tinnitus, and a history of noise exposure (p < 0.001). Participants that reported any dizziness had significantly higher prevalence of hypertension, blood pressure medication use, and higher body mass index (BMI). Individuals with symptoms alluding to an orthostatic or migraine etiology had significant differences in prevalence of hypertension, blood pressure medication use, and BMI (p < 0.001). Alternatively, cardiometabolic variables were not significantly related to the report of dizziness symptoms consistent with vestibular profiles. Conclusion Dizziness among African Americans is comparable to the general population with regards to age and sex distribution, accordingly to previously published estimates. Participants with dizziness symptoms appear to have significant differences in BMI and blood pressure regulation, especially with associated orthostatic or migraine type profiles; this relationship does not appear to be conserved in participants who present with vestibular etiology symptoms.

Abstract P149: Rural Residence And Blood Pressure Medication Use In United States Stroke Survivors, 2019 Behavioral Risk Factor Surveillance System Survey

Hypertension ◽  
2021 ◽  
Vol 78 (Suppl_1) ◽  
Author(s):  
Phoebe Tran ◽  
Lam Tran ◽  
Inna Polyakova
Keyword(s):  
Blood Pressure ◽  
Rural Areas ◽  
Urban Areas ◽  
Recurrent Stroke ◽  
Medication Use ◽  
Behavioral Risk ◽  
Stroke Survivors ◽  
Blood Pressure Medication ◽  
Rural And Urban ◽  
Behavioral Risk Factor Surveillance

Background: Over the last two decades, recurrent stroke rates and hypertension rates have increased significantly in rural US areas. Blood pressure medication use is associated with lower recurrent stroke risk, but information on blood pressure medication use after stroke in rural areas is limited. We sought to compare blood pressure medication use in US stroke survivors living in rural versus urban areas. Methods: We identified US stroke survivors with hypertension in the national 2019 Behavioral Risk Factor Surveillance System survey. The survey-weighted prevalence of current blood pressure medication use was determined by rural and urban residence status. Survey-weighted logistic regression was used to calculate unadjusted Odds Ratios (OR) of current blood pressure medication use as well as ORs adjusted for stroke/hypertension related sociodemographic factors. We further stratified blood pressure medication use by other lifestyle factors in rural and urban settings. Results: Our study included 51,161 people who had a stroke, of which 18,097 were rural residents ( Table ). In weighted analyses, medication use was comparable for rural and urban residents. Stroke survivors in rural areas had similar odds of medication use as those in urban areas before and after risk-adjustment. Medication use did not vary by smoking status, physical inactivity, and high cholesterol between rural and urban residents. Conclusions: Overall, post-stroke blood pressure medication use was high and did not differ by rural/urban status or lifestyle factors. Other factors such as post-discharge care may have a greater impact on recurrent stroke rates in US rural areas.

METABOLIC SYNDROME IN DIALYSIS PATIENTS

2016 ◽  
pp. 7-11
Author(s):  
Vinh Phu Hoang ◽  
Tam Vo ◽  
Van Tien Le ◽  
Thi Hoai Huong Vo
Keyword(s):  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
Artificial Kidney ◽  
Dialysis Patients ◽  
Cross Sectional ◽  
Average Value ◽  
The Metabolic Syndrome ◽  
End Stage

Objective: To review disorders elements of the metabolic syndrome in patients with end-stage chronic renal failure on dialysis cycle. Materials and methods: A cross sectional descriptive study of 85 patients including end-stage chronic renal failure in dialysis cycle from 5/2015 - 9/2016 at the Department of Artificial Kidney, Hue Central Hospital. Results: The prevalence of metabolic syndrome in dialysis patients was 37.65%. The prevalence of abdominal obesity was 30.6%; The prevalence of hypertension was 72.9%, the average value systolic blood pressure and diastolic blood pressure were 142.24 ± 27.53, 80.35 ± 12.48 mmHg; The prevalence of hyperglycemia was 28%, the average value blood glucose was 4.9 ± 1.19 mmol/l; The prevalence of triglyceride increase was 34.1%, the average value triglyceride was 1.59 ± 0.84 mmol/l. The prevalence of HDL-C increase was 47.1%, the average value HDL-C was 1.24 ± 0.33 mmol/l. Conclusion: The prevalence of metabolic syndrome in dialysis patients is very high, in which hypertension and HDL disturbances are the highest. Key words: chronic renal failure, dialysis, metabolic syndrome

scholarly journals Positive and Negative Aspects of Sodium Intake in Dialysis and Non-Dialysis CKD Patients

Nutrients ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 951
Author(s):  
Yasuyuki Nagasawa
Keyword(s):  
Blood Pressure ◽  
Nutritional Status ◽  
Water Intake ◽  
Salt Intake ◽  
Sodium Intake ◽  
Extracellular Fluid ◽  
Sodium Restriction ◽  
Dialysis Patients ◽  
Positive Effects ◽  
Volume Blood

Sodium intake theoretically has dual effects on both non-dialysis chronic kidney disease (CKD) patients and dialysis patients. One negatively affects mortality by increasing proteinuria and blood pressure. The other positively affects mortality by ameliorating nutritional status through appetite induced by salt intake and the amount of food itself, which is proportional to the amount of salt under the same salty taste. Sodium restriction with enough water intake easily causes hyponatremia in CKD and dialysis patients. Moreover, the balance of these dual effects in dialysis patients is likely different from their balance in non-dialysis CKD patients because dialysis patients lose kidney function. Sodium intake is strongly related to water intake via the thirst center. Therefore, sodium intake is strongly related to extracellular fluid volume, blood pressure, appetite, nutritional status, and mortality. To decrease mortality in both non-dialysis and dialysis CKD patients, sodium restriction is an essential and important factor that can be changed by the patients themselves. However, under sodium restriction, it is important to maintain the balance of negative and positive effects from sodium intake not only in dialysis and non-dialysis CKD patients but also in the general population.

scholarly journals Does Intravenous Erythropoietin Lead to an Immediate, Transient Increase in Arterial Blood Pressure in Dialysis Patients?

Nephron ◽  
1994 ◽  
Vol 67 (2) ◽  
pp. 240-241 ◽  
Author(s):  
Malik Touam ◽  
Jorge Perez Oliva ◽  
Johanna Zingraff ◽  
Tilman Drüeke
Keyword(s):  
Blood Pressure ◽  
Arterial Blood Pressure ◽  
Transient Increase ◽  
Dialysis Patients ◽  
Arterial Blood

scholarly journals Blood pressure variability in hemodialysis patients: prognostic significance and treatment possibilities

2020 ◽  
Vol 92 (4) ◽  
pp. 91-97
Author(s):  
A. S. Tokareva ◽  
N. Yu. Borovkova
Keyword(s):  
Blood Pressure ◽  
Clinical Significance ◽  
Blood Pressure Variability ◽  
Antihypertensive Drugs ◽  
Prognostic Significance ◽  
Hemodialysis Patients ◽  
Present Review ◽  
Dialysis Patients ◽  
Current State ◽  
Randomized Studies

A present review is devoted to the current state of the problem of blood pressure variability (BPV) in hemodialysis patients. The BPV classification and clinical significance of BPV metrics are discussed. The results of cohort and randomized studies on the high BPV influence on outcomes in hemodialysis patients, as well as on the possibilities of antihypertensive drugs in the treatment of high BPV in dialysis patients, are presented.

Sign in / Sign up

Export Citation Format

Share Document